Electrophysiology Research Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2015
NCT02561897
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Electrophysiology Research Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

edoxaban (savaysa) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2